Drug discovery and development companies

Absci Corporation, a generative AI drug discovery and development company, announced on January 8 that it has entered into a strategic partnership with AMD to deploy AMD Instinct gas pedals and ROCm software to support key AI drug discovery and development workloads, including Absci's from-scratch antibody design models.AMD will also invest $20 million (currently approximately Rs. 147 crores) in Absci in the form of a private investment in equity (PIPE). AMD will also invest $20 million in Absci in the form of a private equity investment (PIPE) (I note: currently approximately RMB 147 million). Absci says this shows that in drug...